DaVita Inc (DVA)

Industry Medical Care Facilities
This stock can be held in an Investment ISA and an Investment Account
Sell

$144.10

Buy

$144.40

arrow-up$0.37 (+0.26%)

DaVita Inc is engaged in operating kidney dialysis centers and providing related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives.
Prices updated at 12 May 2025, 15:39 BST
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up2.79%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Care Facilities
Chairman
Ms. Pamela M. Arway
CEO
Mr. Javier J. Rodriguez
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
76,000
Head office
2000 16th Street
Denver
United States
80202
mobile
+1 720 631-2100
letter
ir@davita.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Barbara J. Desoer
Independent Director
0.19m--0.38m-
Mr. Charles G. Berg
Independent Director
0.12m--0.32m-
Mr. Javier J. Rodriguez
Director and Chief Executive Officer
1.50m--21.81m-
Mr. Joel Ackerman
Chief Financial Officer and Treasurer
0.77m--6.35m-
Ms. Phyllis R. Yale
Non-Executive Independent Director
0.18m--0.37m-
Mr. Adam H. Schechter
Independent Director
0.14m--0.33m-
Ms. Wendy L. Schoppert
Independent Director
0.14m--0.33m-
Ms. Pamela M. Arway
Chairman of the Board
0.30m--0.50m-
Mr. Michael David Staffieri
Chief Operating Officer Emeritus
0.80m--8.30m-
Mr. Christopher M. Berry
Chief Accounting Officer
-----
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
0.73m--4.65m-
Mr. Jason M. Hollar
Independent Director
0.17m--0.37m-
Mr. James O. Hearty
Chief Compliance Officer
0.57m--2.34m-
Dr. Gregory J. Moore, M.D.
Independent Director
0.18m--0.38m-
Mr. Dennis W. Pullin
Independent Director
-----
Mr. David P. Maughan
Chief Operating Officer, DaVita Kidney Care
0.62m--4.93m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Berkshire Hathaway Inc36,095,5702.02043--30 Apr 202546.96
Vanguard Group Inc5,214,8150.01358-170752-3.17054830 Apr 20256.78
BlackRock Inc4,233,4000.01281-465288-9.90250930 Apr 20255.51
State Street Corp2,343,7280.01383-68934-2.85717630 Apr 20253.05
BlackRock Fund Advisors1,803,5643.6908-168654-30 Apr 20252.35

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
02 Dec 2024-Ms. Phyllis R. Yale--12,504--
27 Nov 2024-Ms. Kathleen Alyce Waters--8,079--
27 Nov 2024-Ms. Kathleen Alyce Waters167.96241,69491,028--
27 Nov 2024-Ms. Kathleen Alyce Waters167.96879,94292,467--
27 Nov 2024-Ms. Kathleen Alyce Waters108.93879,93797,706--
15 Nov 2024-Ms. Barbara J. Desoer--312--
15 Nov 2024-Mr. Charles G. Berg--19,285--
15 Nov 2024-Mr. Javier J. Rodriguez--875,258--
15 Nov 2024-Ms. Phyllis R. Yale--16,004--
15 Nov 2024-Mr. Adam H. Schechter--3,633--
15 Nov 2024-Ms. Wendy L. Schoppert--1,828--
15 Nov 2024-Ms. Pamela M. Arway--24,886--
15 Nov 2024-Mr. Jason M. Hollar--4,546--
15 Nov 2024-Mr. Gregory J Moore--5,754--
15 Nov 2024-Mr. Dennis W. Pullin--612--
16 Sep 2024-Mr. Joel Ackerman75.955,999,974185,740--
16 Sep 2024-Mr. Joel Ackerman-----
16 Sep 2024-Mr. Joel Ackerman163.563,533,223127,454--
16 Sep 2024-Mr. Joel Ackerman163.566,000,035149,056--
16 Sep 2024-Mr. Javier J. Rodriguez165.058,252,515837,835--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.